TG Therapeutics: 3Q Earnings Snapshot

November 9, 2018

NEW YORK (AP) _ TG Therapeutics Inc. (TGTX) on Friday reported a loss of $34 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 43 cents.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.

The biopharmaceutical company posted revenue of $38,000 in the period, meeting Street forecasts.

TG Therapeutics shares have fallen 36 percent since the beginning of the year. The stock has declined 32 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX

Update hourly